Clinical trial
Investigating the Potential of Novel Dementia Biomarkers - an MRI, fNIRS and EEG Study
NCT04427436 is registered in ClinicalTrials.gov with German Center for Neurodegenerative Diseases (DZNE) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Potential of Novel Dementia Biomarkers - an MRI, fNIRS and EEG Study
- Lead sponsor
- German Center for Neurodegenerative Diseases (DZNE)
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- December 31, 2021
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, early onset